Latest Breaking News On - Gastroesophageal junction - Page 1 : comparemela.com

U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA).

Japan
United-states
Australia
Canada
Tokyo
Shitara
Aichi
United-kingdom
American
America
Moitreyee-chatterjee-kishore
Naoki-okamura

ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update

ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Colorado
United-states
California
Chicago
Illinois
San-diego
Texas
American
Jason-lettmann
Allison-dillon
Academic-gi-cancer-consortium
Development-rd-expenses

Keytruda Combo Boosts Survival in Gastric Cancer Subtype

For certain patients with HER2-positive gastric cancers, a Keytruda treatment combination has shown promising survival outcomes.

Merck-research-laboratories
National-cancer-institute
Survival-outcomes
Gastroesophageal-junction
Marjorie-green
Merck-research
News
Gastric-cancer
Gastroesophageal-junction-cancer
Keytruda

FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer

PT886 (Phanes Therapeutics) received fast track designation 2 years after receiving orphan drug designation by the FDA.

United-states
Ming-wang
Phanes-therapeutics-inc
Phanes-therapeutics
Patients-with
Advanced-gastric
Gastroesophageal-junction
Fast-track
Therapeutics-announces-first-patient-dosed
Announces-clinical-trial-collaboration
Supply-agreement

BeiGene, Ltd.: BeiGene's Biologics License Application for TEVIMBRA (tislelizumab) for First-Line Gastric or Gastroesophageal Junction Cancers Accepted by FDA

BeiGene, Ltd.: BeiGene's Biologics License Application for TEVIMBRA (tislelizumab) for First-Line Gastric or Gastroesophageal Junction Cancers Accepted by FDA
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Beijing
China
United-states
France
Laversanne
Rhôalpes
Cambridge
Cambridgeshire
United-kingdom
Lesen
Aquitaine
American